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NICOTINATES and benzalkonium chloride (B.C1) cause in-
flammatory changes in human skin, thought to be de-
pendent upon prostaglandin formation. This study has
examined the effects of hexyl-nicotinate (HN) and B.CI
on blood flow in porcine skin. The role of prostaglandins
and interleukin (IL)-I in the blood flow response has been
investigated. Blood flow was increased by both HN and
B.C1, the response to B.C1 being more protracted. Cyclo-
oxygenase inhibitor pretreatment reduced these responses.
IL-l-like biological activity was identified in normal por-
cine epidermis and the amounts recovered from inflamed
skin were similar. Thus prostaglandin formation in HN
or B.Cl-induced inflammation, if IL-1 dependent, is not
associated with the loss of significant amounts of the
cytokine from the epidermis.
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Introduction
Nicotinate esters have, for many years, been
included in rubefacient preparations, which are
thought to relieve pain by acting as counter
irritants. Topical application of nicotinates to
human skin has been shown to cause erythema, an
increase in blood flow, oedema and leucocyte
infiltration. 1’2 These compounds, together with
benzalkonium chloride (B.Cl), a skin disinfectant
which has also been shown to produce inflam-
matory effects in human skin,
3 have been used to
study the mechanisms underlying aspects of the
cutaneous response to local irritation. Thus
prostaglandins (PGs) have been implicated in the
pathogenesis of the inflammatory response to
nicotinates and B.C1. Increased amounts of PGE2
have been recovered from suction blisters raised on
Trafuril (R) (tetrahydrofurfuryl-nicotinate) and B.C1-
inflamed skin and inhibitors ofPG synthesis shown
to reduce both the erythematous and cellular
responses to the nicotinate.
2-4 Whether PG
formation occurs as a direct result of damage to
cells in the epidermis or dermis by such compounds,
or indirectly via the release of a second mediator(s),
has not been determined.
Normal human skin contains large amounts of
the cytokine interleukin (IL)-I and injurious stimuli
have been reported to cause the synthesis or release
of membrane bound IL-1 from keratinocytes in
vitro.
1 Since IL-1 can induce the formation of
vasodilator PGs in cultured keratinocytes and
endothelial cells,11’2 this cytokine may play a role
in the PG production that accompanies the
inflammatory response to nicotinate esters and B.C1.
The structure of porcine skin closely resembles
(C) 1992 Rapid Communications of Oxford ktd
that of man.
13 Studies of such physiological and
pathophysiological processes as epidermal cell
kinetics, ultraviolet light induced skin damage and
responses to inflammatory mediators have also
yielded similar results to those obtained in human
skin.
14-6 We now report a method which has been
devised to examine the effects of topically applied
hexyl-nicotinate (HN) and B.Cl on blood flow in
mini-pig skin. The role of PGs and IL-1 in
mediating such responses has also been invest-
igated.
Materials and Methods
Reagents: IL-10 was a gift from Dr. S. Gillis,
Immunex Corporation, USA, and flunixin meglu-
mine (Finadyne paste) from Dr. P. Smitherman,
Schering-Plough, UK. Tritiated PGE2 (specific
activity 168.7 Ci mmo1-1) was purchased from New
England Nuclear, UK and H-thymidine (specific
activity 25 Ci mmol-) from Amersham Interna-
tional, UK. PGE2 antibody was supplied by ICN
Biomedicals, UK. All other reagents were pur-
chased from Sigma Chemical Co., UK or Aldrich
Ltd., UK and were of Analar grade.
Measurement of cutaneous blood/tow: Mini-pigs (Gottin-
gen strain; 15-25 kg) were trained to sit in a
specially constructed box with a moveable side,
comprised of removable bars, to enable blood flow
to be measured with a laser Doppler flowmeter
(Pf2b, Perimed, Sweden). Circular sites of 3.5 cm
diameter were marked on the flanks, which had
been clipped the previous day, and background
blood flow readings obtained. Fifty /1 of vehicle
(dimethylsulphoxide (DMSO) and propylene
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glycol:isopropanol (PG:IPA;60:40) for B.C1 and
HN respectively) was then applied topically under
occlusion for 30 min. HN, B.C1 or vehicle (50 #1)
were next applied under occlusion for a further
15 min and blood flow recorded at regular intervals
until the responses reached a peak. Five readings
were obtained at each site and the mean value
calculated for each time point. Ten per cent
solutions ofHN and B.C1 were used as preliminary
experiments had shown that 5 mg/site was the
smallest amount of either compound that produced
consistent increases in blood flow in all the pigs
tested.
Effect of cyclo-oxygenase inhibition on HN and B.Cl-induced
inqammatory responses: Inter-site variation in the blood
flow response was first examined by applying HN
to two sites on each of four pigs. HN and PG:IPA
were next applied to two different sites and blood
flow responses measured prior to oral administra-
tion of 5 mg kg
-1 flunixin meglumine (Finadyne
paste). HN and PG:IPA were then applied to two
further, matched, sites on the opposite flank,
2.5-4.5 h after drug administration. A 5 mg kg
-1
dose of flunixin was chosen because, when
administered to calves at a dose of 4.4 mg kg-1, the
drug inhibited cyclo-oxygenase product formation
in inflammatory exudates by more than 98% for at
least 12 h (P. Lees, Royal Veterinary College;
personal communication). In a second, similar,
experiment in the same four pigs, blood flow
responses to B.C1 and DMSO were examined before
and after flunixin administration although, in view
of the protracted blood flow response to B.C1,
pre- and post-drug measurements had to be carried
out on successive days. The increases in blood flow
caused by HN and B.C1 were then compared to
pre-treatment values. Skin samples were taken from
two pigs for measurement of PGE2, 4 and 7 h after
flunixin administration.
Skin sampling for measurement of PGE and Ig-l-like
activity: Samples were first obtained to determine
background levels of PGE2 and IL-l-like biological
activity in normal porcine skin. Inter-site variation
in the recovery of these mediators was also
measured. Local anaesthetic (1% lignocaine) was
injected and skin samples collected 10 min later
using a motor-driven keratotome (Storz, USA).
The keratotome was set to a depth of 0.3 mm
(epidermal and dermal tissue) when collecting
samples for estimation of PGE2 and 0.1 mm for
measurement of epidermal IL-1. The samples were
snap-frozen in liquid nitrogen and stored at -20C
until required for analysis.
In two separate experiments HN, B.C1 and the
appropriate vehicles were applied to sites on the
flanks of four mini-pigs. Samples were obtained
from treated sites at the time of the maximum
increase in blood flow caused by HN or B.C1 and
the amount of IL-l-like activity in inflamed skin
compared to that in vehicle treated sites. PGs could
not be measured in inflamed skin since both HN
and B.C1 were found to prevent PG extraction from
the skin.
Preparation of samples for measurement of PGE2: Frozen
skin samples were powdered in liquid nitrogen and
50 mg aliquots added to 1 ml absolute ethanol. The
samples were then homogenized three times, the
supernatants pooled and the ethanol evaporated
under a stream of nitrogen. After reconstituting in
10 ml Tris buffer (0.01 M, pH 7.0) and acidifying
to pH 2-3 with 1 M citrate, samples were passed
through prepared non-polar columns (functional
group ethyl, 100 mg capacity, Bond-Elut) which
retain PGE2. The eluates were discarded, the
columns washed with 4 250 #1 toluene:di-
chloromethane (60:40) and eluted with 4 250 #1
ethyl acetate:acetic acid (98:2). After evaporation
of the solvents under nitrogen the samples were
reconstituted in buffer for measurement of PGE2
by radioimmunoassay (RIA).
Preparation of samples for measurement of IL-1-1ike activity:
Aliquots ofpowdered skin were homogenized three
times in RPMI-1640 buffer (15 mg in 0.8 ml). The
supernatants from successive homogenizations
were pooled, passed through a 0.2/zm filter and
serial dilutions prepared. Epidermal IL-l-like
activity was quantitated by use of a two-stage
bioassay requiring EL4-NOB-1 and CTLL cells,
which has been described in detail elsewhere.
17 The
IL-l-like activity in porcine epidermal homogenates
was quantitated by reference to a standard curve to
human recombinant IL-l carried out in the same
assay and results expressed as pg human re-
combinant IL-10 equivalents/mg wet weight skin.
Porcine IL-10 has been reported to be equivalent
in activity to murine IL-10 in this assay system
although porcine IL-lfl is two orders of magnitude
less active.
8 Human recombinant IL-I and fl
(Immunex) are equivalent in activity to murine
IL-10 (A.J.H. Gearing, personal communication).
Anion-exchange chromatography: Aliquots (37.5 rag) of
powdered porcine epidermis were homogenized in
3 2 ml 20 mM Tris acetate buffer, pH 4. The
supernatants were pooled and approximately one
third of the sample then purified on a 7.5 cm
7.5 mm TSK-DEAE-5-PW column (BioRad, UK),
eluted with a gradient of 20 mM Tris acetate buffer
over 20min at a flow rate of lmlmin-, as
previously described for psoriatic scale and normal
heel callus.
19 One ml fractions were collected,
evaporated overnight and stored at -20C until
required for analysis in the IL-1 bioassay. Each
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fraction was reconstituted in 0.3 ml RPMI-1640
buffer and assayed at a dilution of 1" 10.
Results
Effect ofHN and B. C1 on bloodqow: Topical application
of both HN and B.C1 caused a significant increase
in blood flow, when compared to the vehicle and
the response was usually accompanied by visible
erythema. The time taken to reach the maximum
response was consistent in all animals (Table 1),
however, as illustrated in Fig. 1, the time course of
the response to the two compounds differed. The
Table 1. Effect of HN and B.CI on blood flow in
mini-pig skin
Time to reach Maximal
maximum blood increase in
flow blood flow
(min)
HN 12 50 + 3.3 *43 + 7
PG’IPA 12 15.0 4- 3
B.CI 12 246 4- 24 *46 4- 6
DMSO 12 15 4-3
Results are expressed as mean 4- SEM blood flow
(arbitrary units) p < 0.001 versus vehicle (paired
Student’s t-test).
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FIG. 1. Blood flow after topical application of A: HN() and PG:IPA
(El---I--J) and B: B.CI (H) and DMSO (C)--O) to the skin of one
pig. (<) denotes background blood flow. The solid bar indicates the
period of application of H N or B.CI under occlusion (15 min).
Table2. Effect of flunixin on H N and B.Cl-
induced blood flow responses
aMaximal relative blood flow
n Pre-flunixin Post-flunixin
HN 4 2.5 + 0.1 "1.3 + 0.1
B.CI 3 4.2+0.7 1.6+0.2
blood flow + HN or B.CI
Relative blood flow
blood flow + vehicle
p < 0.05 versus pre-treatment values (paired
Student’s t-test)
B.Cl-induced increase in blood flow was not usually
seen until at least 2 h, peaked at 4-6 h and often
remained above background for more than 7 h. In
contrast HN caused an increase in blood flow which
was evident as early as 20 min after application,
became maximal at 40-60 min and was approaching
background values by 90 min. DMSO and PG"IPA
caused a small increase in blood flow in some
animals which persisted for no more than 30 min.
In addition to causing an increase in blood flow
B.C1 also provoked oedema formation in nine of
the twelve pigs. Small blisters were also seen in
some pigs approximately 10 h after application of
B.C1.
Effect ofdqunixin on HN and B.Cl-induced increases in blood
/tow" Administration of flunixin inhibited the
maximum blood flow response to HN by
46.4-+-1.3%, a statistically significant reduction
(Table 2). In addition the erythema that accom-
panied the increase in blood flow was abolished by
drug treatment. Blood flow responses to HN at
different sites in individual animals did not vary by
more than 22%.
The blood flow response to B.C1 was also
inhibited by flunixin treatment but the reduction
did not achieve statistical significance (Table 2).
This is likely to be due to the variability of the
responses obtained since, although in two of the
four pigs the increase in blood flow was completely
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inhibited, as were visible signs of erythema and
oedema, in the third there was only a 35% reduction
in the response. In addition the fourth pig did not
respond to 10% B.C1 and application of a 15%
solution caused early oedema formation which
precluded measurement of blood flow. Flunixin had
no effect on the development ofoedema in this pig.
Keratotome biopsies of normal porcine skin
obtained from six pigs contained 1.18 4-0.09 ng
PGEe/mg wet weight tissue (mean SEM). These
values have not been corrected for recovery which
was found to be 86 _--k 2.6% (mean 4- SEM; n 26
columns). Inter-site variation in PGE2, determined
by measuring the amounts present in three samples
from each of four pigs, was 12.2 ___
5.0% (mean -+-
SEM). PGE2 levels in flunixin treated animals,
measured after 4 and 7h, were below the
detection limit of the RIA (< 15 pg/mg wet weight
of tissue).
IL-l-like activity in porcine epidermis" IL-l-like activity
was detected in 0.1 mm depth keratotome biopsies
obtained from mini-pig skin (408 80 pg IL-10
equivalents/mg wet weight tissue; mean SEM;
n 8). Stratum corneum also contained IL-l-like
biological activity (459 144 pg IL-10 equiva-
lents/mg wet weight tissue; mean -+- SEM; n- 4).
Inter-site variation was determined by measuring
the IL-l-like activity in three samples from each of
four pigs and found to be 15.2-+-2.9%. Assay of
one sample from each of three pigs on four separate
occasions showed the inter-assay variation to be
8.1 -+- 2.3% (mean SEM).
The amount of 1L-l-like activity in HN and B.C1
treated sites at the time of the maximum increase
in blood flow was found to be similar to that in
vehicle treated skin (Table 3). Neither HN nor B.C1
5OOO0
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FIG. 2. IL-l-like biological activity obtained on anion exchange
chromatographic separation of porcine epidermis. The retention times of
pl markers are shown (X, myoglobin, pl 6.76, 7.1 6; Y, carbonic anhydrase,
pl 5.85; Z, fl-lactoglobulin, pl 5.1 3). One minute fractions were collected,
evaporated overnight and reconstituted in 0.3ml RPMI-1640 prior to
bioassay. Samples were assayed in triplicate following 1:10 dilution.
Table 3. Effect of HN and B.CI on IL-1 -like activity in mini-pig
skin
Treatment n IL-1 (pg human IL-10 equivalents/mg wet
weight tissue)
PG’IPA 4 579 ___
139
HN 4 413 + 31
DMSO 4 359 + 104
B.CI 4 361 + 89
Results are expressed as mean _+ SEM.
interfered with the bioassay at the dilutions used to
assay the samples (typically 1"64 to 1"2048; data
not shown).
Anion exchange chromatography: Figure 2 shows a
representative trace obtained after purification of
porcine epidermal IL-l-like activity by anion
exchange chromatography. Biological activity in
the EL4-NOB-1 assay was only obtained in
fractions eluting in the acidic region. Similar results
were obtained in a further two experiments (data
not shown). In view of the broad nature of the peak
of IL-l-like activity and the steep transition from
neutral to acid pH obtained with the Tris acetate
gradient system used, a pI value cannot be assigned
with any accuracy. Nevertheless it seems likely that
the biological activity in the pi4-5 region is due to
porcine IL-10 (pI5).
Discussion
A method has been developed for quantitative
measurement of the effects of topically applied
chemical irritants and nicotinate esters on blood
flow in mini-pig skin. Both of the compounds used
in this study, HN and B.C1, significantly increased
blood flow. The time course of the responses,
however, differed, one explanation for this being a
difference in the percutaneous absorption character-
istics of HN and B.C1. The maximal increase in
blood flow produced by HN was seen within an
hour whereas B.C1 caused a much more protracted
increase in blood flow that did not reach a peak
until about 4 h after administration. Similar time
courses for erythematous and blood flow responses
have been reported in man, although HN was
applied to human skin in lotion and B.C1 as an
aqueous solution added to lyofoam within a skin
chamber, rather than the solvents which were used
when applying these compounds to porcine skin.
Despite this, in man the increase in blood flow
caused by HN was reported to be maximal after
some 20 min and to return to baseline by 80 min.
The erythema seen after application of B.C1 has
been described as being most intense after 4 h.
The reduction in the blood flow response to HN
and B.C1 observed in porcine skin after pretreat-
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ment with the cyclo-oxygenase inhibitor flunixin
meglumine suggests that, as in man,
2-4 PGs are
involved in mediating such responses. However,
the mechanism by which such PG formation is
brought about has yet to be established. HN or B.C1
could, for example, stimulate PG production
directly or, alternatively, synthesis could occur
indirectly via the release of another mediator.
We have now shown 1L-l-like biological activity
to be present in mini-pig epidermis. Anion
exchange chromatographic purification of the
epidermal samples led to recovery of the biological
activity in the pi4-5 region, where porcine IL-lo
would be expected to elute. One explanation for the
absence of such activity in the neutral region could
be that only trace amounts of IL-1/ are present in
porcine epidermis. Measurement of small quantities
of this cytokine would be further hindered by the
lower potency of porcine IL-lfl relative to IL- in
the EL4-NOB-1 assay.
18 Alternatively, IL-1/ could
be present in the unprocessed, precursor, form
which is biologically inactive.2 Others have
reported the presence of IL-I in porcine epidermis
using immunohistochemical methods and a purified
antiserum to porcine IL-l.
21 An antiserum to
IL-1/ was not used. Negative staining was obtained
in porcine stratum corneum in this study, which
contrasts with our finding of IL-l-like biological
activity.
Injurious stimuli, including ultraviolet light,
have been reported to induce the release of IL-1
from human keratinocyte membranes in vitro. 8’9
Furthermore endothelial cells can generate PGs
when incubated with supernatants from irradiated
keratinocytes which contain IL-1.
22 If the PG
formation that occurs in porcine skin after topical
application of compounds such as B.C1 or HN is
brought about by IL-1 mobilization from the
epidermis and subsequent endothelial cell stimula-
tion, a decrease in the epidermal IL-1 content might
be expected. No significant difference was,
however, observed between the amounts of IL-1 i,n
vehicle treated sites, at which only slight, transient,
increases in blood flow were detected in some pigs,
and inflamed skin to which HN or B.C1 had been
applied. One possible explanation may be that the
amounts of IL-1 required to induce PG release are
very small and hence any differences are obscured
by the inter-site variation in IL-1 recoveries.
Alternatively IL-1 could be released within the
epidermal compartment to interact with cells
activated by HN or B.C1 since, in vitro, IL-1 has
been shown to induce PG release from human
keratinocytes.
11 Further studies will be required to
establish the nature of any interaction between IL-1
and PG formation in vivo in porcine skin during the
inflammatory response to nicotinates and chemical
irritants.
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